Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Apr 01, 2024
Striving for Uniformity: A Review on Advances and Challenges To Achieve Uniform Polyethylene Glycol
Read more
Scientific Article
/ May 06, 2024
Ten years of the manufacturing classification system: a review of literature applications and an extension of the framework to continuous manufacture
Read more
Scientific Article
/ Dec 28, 2023
Pharmaceutical composition containing sugar and lipid composite particles for inhalation and method for manufacturing same
Read more
Scientific Article